newsfilter
← Latest News
GlobeNewswire·

NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock

PITTSBURGH, April 22, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase"), a biotechnology company accelerating the genetic revolution with a new class of precision genetic medicines, announced today the pricing of an underwri